Ohara Y - Search Results

1

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.

Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, Kamada T, Irie T, Okumura G, Kono H, Ito D, Fujii R, Watanabe S, Sai A, Fukuoka S, Sugiyama E, Watanabe G, Owari T, Nishinakamura H, Sugiyama D, Maeda Y, Kawazoe A, Yukami H, Chida K, Ohara Y, Yoshida T, Shinno Y, Takeyasu Y, Shirasawa M, Nakama K, Aokage K, Suzuki J, Ishii G, Kuwata T, Sakamoto N, Kawazu M, Ueno T, Mori T, Yamazaki N, Tsuboi M, Yatabe Y, Kinoshita T, Doi T, Shitara K, Mano H, Nishikawa H. Kumagai S, et al. Among authors: ohara y. Cancer Cell. 2022 Feb 14;40(2):201-218.e9. doi: 10.1016/j.ccell.2022.01.001. Epub 2022 Jan 28. Cancer Cell. 2022. PMID: 35090594 Free article.

2

The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma.

Nagasaki J, Togashi Y, Sugawara T, Itami M, Yamauchi N, Yuda J, Sugano M, Ohara Y, Minami Y, Nakamae H, Hino M, Takeuchi M, Nishikawa H. Nagasaki J, et al. Among authors: ohara y. Blood Adv. 2020 Sep 8;4(17):4069-4082. doi: 10.1182/bloodadvances.2020002098. Blood Adv. 2020. PMID: 32870971 Free PMC article.

3

Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy.

Ishii T, Suzuki A, Kuwata T, Hisamitsu S, Hashimoto H, Ohara Y, Yanagihara K, Mitsunaga S, Yoshino T, Kinoshita T, Ochiai A, Shitara K, Ishii G. Ishii T, et al. Among authors: ohara y. Gastric Cancer. 2021 Jul;24(4):810-822. doi: 10.1007/s10120-021-01174-9. Epub 2021 Apr 9. Gastric Cancer. 2021. PMID: 33837489

4

Clinicopathological characteristics associated with necrosis in pulmonary metastases from colorectal cancer.

Suzuki J, Kojima M, Aokage K, Sakai T, Nakamura H, Ohara Y, Tane K, Miyoshi T, Sugano M, Fujii S, Kuwata T, Ochiai A, Ito M, Suzuki K, Tsuboi M, Ishii G. Suzuki J, et al. Among authors: ohara y. Virchows Arch. 2019 May;474(5):569-575. doi: 10.1007/s00428-019-02535-7. Epub 2019 Feb 14. Virchows Arch. 2019. PMID: 30762121

5

Connective tissue growth factor produced by cancer‑associated fibroblasts correlates with poor prognosis in epithelioid malignant pleural mesothelioma.

Ohara Y, Enomoto A, Tsuyuki Y, Sato K, Iida T, Kobayashi H, Mizutani Y, Miyai Y, Hara A, Mii S, Suzuki J, Yamashita K, Ito F, Motooka Y, Misawa N, Fukui T, Kawaguchi K, Yokoi K, Toyokuni S. Ohara Y, et al. Oncol Rep. 2020 Sep;44(3):838-848. doi: 10.3892/or.2020.7669. Epub 2020 Jul 3. Oncol Rep. 2020. PMID: 32705221 Free PMC article.

6

Dual preventive benefits of iron elimination by desferal in asbestos-induced mesothelial carcinogenesis.

Jiang L, Chew SH, Nakamura K, Ohara Y, Akatsuka S, Toyokuni S. Jiang L, et al. Among authors: ohara y. Cancer Sci. 2016 Jul;107(7):908-15. doi: 10.1111/cas.12947. Epub 2016 Jun 13. Cancer Sci. 2016. PMID: 27088640 Free PMC article.

7

Phlebotomy as a preventive measure for crocidolite-induced mesothelioma in male rats.

Ohara Y, Chew SH, Shibata T, Okazaki Y, Yamashita K, Toyokuni S. Ohara Y, et al. Cancer Sci. 2018 Feb;109(2):330-339. doi: 10.1111/cas.13460. Epub 2018 Jan 4. Cancer Sci. 2018. PMID: 29193587 Free PMC article.

8

Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.

Wang S, Jiang L, Han Y, Chew SH, Ohara Y, Akatsuka S, Weng L, Kawaguchi K, Fukui T, Sekido Y, Yokoi K, Toyokuni S. Wang S, et al. Among authors: ohara y. Oncotarget. 2016 Oct 25;7(43):69565-69578. doi: 10.18632/oncotarget.11829. Oncotarget. 2016. PMID: 27602956 Free PMC article.

9

Rheostatic CD44 isoform expression and its association with oxidative stress in human malignant mesothelioma.

Chew SH, Okazaki Y, Akatsuka S, Wang S, Jiang L, Ohara Y, Ito F, Saya H, Sekido Y, Toyokuni S. Chew SH, et al. Among authors: ohara y. Free Radic Biol Med. 2017 May;106:91-99. doi: 10.1016/j.freeradbiomed.2017.02.011. Epub 2017 Feb 6. Free Radic Biol Med. 2017. PMID: 28185919

10

Connective tissue growth factor-specific monoclonal antibody inhibits growth of malignant mesothelioma in an orthotopic mouse model.

Ohara Y, Chew SH, Misawa N, Wang S, Somiya D, Nakamura K, Kajiyama H, Kikkawa F, Tsuyuki Y, Jiang L, Yamashita K, Sekido Y, Lipson KE, Toyokuni S. Ohara Y, et al. Oncotarget. 2018 Apr 6;9(26):18494-18509. doi: 10.18632/oncotarget.24892. eCollection 2018 Apr 6. Oncotarget. 2018. PMID: 29719620 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

623 results

Search Page